KCM
Kennedy Capital Management Portfolio holdings
AUM
$4.19B
1-Year Return
21.14%
This Quarter Return
+9.84%
1 Year Return
+21.14%
3 Year Return
+81.48%
5 Year Return
+215.31%
10 Year Return
+405%
AUM
$4.19B
AUM Growth
+$8.49M
(+0.2%)
Cap. Flow
-$239M
Cap. Flow
% of AUM
-5.69%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
690
New
48
Increased
226
Reduced
295
Closed
109
Top Buys
| 1 |
Genpact
G
|
+$15.3M |
| 2 |
SharkNinja
SN
|
+$11.8M |
| 3 |
Mercury Systems
MRCY
|
+$9.65M |
| 4 |
SPX Corp
SPXC
|
+$8.6M |
| 5 |
Old Second Bancorp
OSBC
|
+$8.54M |
Top Sells
| 1 |
Hexcel
HXL
|
+$22.7M |
| 2 |
Boot Barn
BOOT
|
+$18.9M |
| 3 |
Columbia Banking Systems
COLB
|
+$14.4M |
| 4 |
Chart Industries
GTLS
|
+$14M |
| 5 |
Informatica
INFA
|
+$13.8M |
Sector Composition
| 1 | Financials | 20.27% |
| 2 | Industrials | 19.02% |
| 3 | Healthcare | 16.19% |
| 4 | Technology | 14.06% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Magnachip Semiconductor
MX
$108M
| $257K | 0.01% |
64,592
-29,800
| -32% | -$119K |
|
552
NewAmsterdam Pharma
NAMS
$3.04B
| $248K | 0.01% |
+13,675
| New | +$248K |
|
553
First Horizon
FHN
$11.3B
| $237K | 0.01% |
11,194
-64,164
| -85% | -$1.36M |
|
554
Advanced Micro Devices
AMD
$246B
| $233K | 0.01% |
+1,640
| New | +$233K |
|
555
MeiraGTx Holdings
MGTX
$601M
| $229K | 0.01% |
35,189
+1,287
| +4% | +$8.39K |
|
556
Emcor
EME
$27.8B
| $226K | 0.01% |
+422
| New | +$226K |
|
557
Wave Life Sciences
WVE
$1.21B
| $221K | 0.01% |
+34,000
| New | +$221K |
|
558
Cytokinetics
CYTK
$6.23B
| $220K | 0.01% |
6,671
+165
| +3% | +$5.45K |
|
559
Janux Therapeutics
JANX
$1.49B
| $220K | 0.01% |
9,508
-7,093
| -43% | -$164K |
|
560
Vaxcyte
PCVX
$4.21B
| $217K | 0.01% |
6,671
+165
| +3% | +$5.36K |
|
561
Kymera Therapeutics
KYMR
$3.09B
| $211K | 0.01% |
+4,836
| New | +$211K |
|
562
Xcel Energy
XEL
$42.4B
| $209K | 0.01% |
3,074
| – | – |
|
563
Ferguson
FERG
$47.7B
| $207K | ﹤0.01% |
+952
| New | +$207K |
|
564
Vanguard Mid-Cap Value ETF
VOE
$18.7B
| $207K | ﹤0.01% |
+1,260
| New | +$207K |
|
565
Snap-on
SNA
$17.1B
| $206K | ﹤0.01% |
661
| – | – |
|
566
Emerson Electric
EMR
$74.7B
| $205K | ﹤0.01% |
+1,539
| New | +$205K |
|
567
Valero Energy
VLO
$48.9B
| $201K | ﹤0.01% |
+1,493
| New | +$201K |
|
568
Black Diamond Therapeutics
BDTX
$174M
| $163K | ﹤0.01% |
65,875
+2,352
| +4% | +$5.83K |
|
569
Trevi Therapeutics
TRVI
$926M
| $152K | ﹤0.01% |
27,851
+595
| +2% | +$3.26K |
|
570
Arcturus Therapeutics
ARCT
$484M
| $152K | ﹤0.01% |
11,674
+544
| +5% | +$7.08K |
|
571
Mitek Systems
MITK
$456M
| $144K | ﹤0.01% |
+14,532
| New | +$144K |
|
|
RAPP
572
Rapport Therapeutics
RAPP
$1.15B
| $128K | ﹤0.01% |
+11,230
| New | +$128K |
|
573
Intellia Therapeutics
NTLA
$1.27B
| $127K | ﹤0.01% |
13,509
+496
| +4% | +$4.65K |
|
|
ATYR
574
aTyr Pharma
ATYR
$535M
| $109K | ﹤0.01% |
+21,514
| New | +$109K |
|
575
Cullinan Oncology
CGEM
$404M
| $91.7K | ﹤0.01% |
12,174
+531
| +5% | +$4K |
|